• ALS News

  Masitinib May Slow ALS Progression

  Posted by MG Community Member on May 7, 2019 at 8:09 am

  

  According to preclinical data, AB Science’s investigational therapy masitinib can modulate different cell types known to be implicated in ALS progression. Click here to learn more.

  What do you think of this news?

  MG Community Member replied 6 years, 11 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply